Zobrazeno 1 - 10
of 13
pro vyhledávání: '"David Goldgrab"'
Autor:
Ana Inashvili, David Goldgrab, Daniel Rodriguez, Darshini Patel, Benjamin Kilpatrick, Juna Misiri, Tehreen Khan, William J. Bugni, Stephen W. Mester
Publikováno v:
Journal of the American College of Cardiology. 81:3673
Publikováno v:
Journal of the American College of Cardiology. 81:3114
Autor:
Ana Inashvili, David Goldgrab, Ruifang Yang, Benjamin Kilpatrick, Devansh Patel, William Bugni, Tehreen Khan, Carlos Leche, Juna Misiri, Stephen W. Mester
Publikováno v:
Journal of the American College of Cardiology. 79:3052
Autor:
Ruifang Yang, Mauricio Gomez, David Goldgrab, Sokol Kalaveshi, Jearim Craig, Stephen Mester, Christian Perzanowski
Publikováno v:
Circulation. 142
Background: Global pandemic of COVID-19 has attracted a number of proposed treatment therapies. Hydroxychloroquine/Azithromycin (HA) combination has been reported to potentially affect repolarization by prolonging the QTc and causing torsades de poin
Autor:
Sokol Kalaveshi, Ruifang Yang, Stephen Mester, David Goldgrab, Jearim Craig, Christian Perzanowski
Publikováno v:
Circulation. 142
Introduction: The COVID-19 has reached pandemic status with significant morbidity and mortality including cardiovascular complications. Systemic inflammation caused by the COVID-19 infection has been associated with an intense release of multiple cyt
Publikováno v:
Chest. 160:A985
Autor:
Christian Perzanowski, Umesh Gowda, Stephen Mester, Juna Misiri, Ruifang Yang, Ranchhod Khant, Tehreen Khan, David Goldgrab
Publikováno v:
Heart Rhythm. 18:S436
Autor:
Ruifang Yang, Ana Inashvili, Stephen Mester, Benjamin Kilpatrick, Tehreen Khan, Umesh Gowda, David Goldgrab
Publikováno v:
Journal of the American College of Cardiology. 77:2353
Autor:
Ruifang Yang, David Goldgrab, William J. Bugni, Stephen Mester, Robert M Dewhurst, Adithya Gandhi
Publikováno v:
Journal of the American College of Cardiology. 75:2946
The risk factor for thromboembolic events after mitral valve repair (MVr) is the absence of antithrombotic therapy. However, the regimen and duration of antithrombotic therapy has been controversial regarding vitamin K antagonist or antiplatelets aft
Publikováno v:
Heart failure reviews. 24(2)
Heart failure (HF) and HF 30-day readmission rates have been a major focus of efforts to reduce health care cost in the recent era. Since the implementation of the Affordable Care Act (ACA) in 2012 and the Hospital Readmission Reduction Program (HRRP